![Nicholas Grund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 377 016 $ in data 30/06/2026
Nicholas P.
Grund is Chief Commercial Officer & Senior Vice President at Akebia Therapeutics, Inc. since 2024.
Formerly, Mr. Grund was Head-Specialty Care at Genzyme Corp.
from 2007 to 2015, Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2016 to 2019, President-Eurofins at Transplant Genomics, Inc. from 2021 to 2022, and Principal at Bayer Diagnostics Corp.
from 1995 to 2002.
Mr. Grund earned an MBA from Northeastern University and completed undergraduate studies at the University of Massachusetts.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 330.716 ( 0,12% ) | 377 016 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 09/01/2024 |
| Società | Posizione | Fine |
|---|---|---|
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Corporate Officer/Principal | 01/11/2022 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29/03/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/12/2015 |
Bayer Diagnostics Corp.
 Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Corporate Officer/Principal | 01/01/2002 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Bayer Diagnostics Corp.
Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
